Document Detail

Effects of supplementation with iloprost on the cardioprotection by BW755C (a dual inhibitor of cyclooxygenase and lipoxygenase enzymes) in myocardial reperfusion injury.
MedLine Citation:
PMID:  9344637     Owner:  NLM     Status:  MEDLINE    
The effect of BW755C (a dual inhibitor of cyclo- and lipoxygenase enzymes) alone and in combination with iloprost (a PGI2 analogue) on myocardial reperfusion injury was investigated in anaesthetised open-chest dogs. The left anterior descending coronary artery was occluded for a period of 40 min followed by reperfusion for 3 h. Dogs were administered either saline, BW755C (10 mg kg-1 slow bolus) or BW755C plus iloprost (100 ng kg-1 min-1 for 75 min) just prior to reperfusion. The haemodynamic data showed significant reduction in MAP and both LV peak-positive and peak-negative dP/dt following reperfusion in the saline-treated group, along with a delayed recovery of LVEDP. These changes were accompanied by significant depletion of myocardial ATP and glycogen stores. Administration of BW755C prevented the haemodynamic changes and replenished the HEP stores. Although coadministration of iloprost with BW755C afforded early normalisation of LVEDP and LV peak positive dP/dt, but MAP and LV peak negative dP/dt remained significantly depressed. Therefore, it might be concluded from this study that supplementation of BW755C with iloprost may have deleterious haemodynamic effects on the reperfused myocardium, particularly in the doses used.
M Maulik; S D Seth; S K Maulik; S C Manchanda
Related Documents :
19881297 - Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia...
7898067 - Role of endothelin during reperfusion after ischemia in isolated perfused rat heart.
8745227 - Preservation of global cardiac function in the rabbit following protracted ischemia/rep...
6156327 - Effect of dipyridamole on ischemia-induced changes in cardiac performance and metabolism.
11157177 - Reproducibility of measurements of cerebral infarct volume on ct scans.
23290547 - Intracoronary enalaprilat to reduce microvascular damage during percutaneous coronary i...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacological research : the official journal of the Italian Pharmacological Society     Volume:  36     ISSN:  1043-6618     ISO Abbreviation:  Pharmacol. Res.     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1998-02-11     Completed Date:  1998-02-11     Revised Date:  2010-01-20    
Medline Journal Info:
Nlm Unique ID:  8907422     Medline TA:  Pharmacol Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  103-8     Citation Subset:  IM    
Copyright Information:
Copyright 1997 The Italian Pharmacological Society.
Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine / therapeutic use*
Blood Pressure / drug effects
Cyclooxygenase Inhibitors / therapeutic use*
Drug Antagonism
Heart / drug effects*,  physiopathology
Heart Rate / drug effects
Iloprost / pharmacology*
Lipoxygenase Inhibitors / therapeutic use*
Myocardial Reperfusion Injury / drug therapy*,  physiopathology
Vasodilator Agents / pharmacology*
Reg. No./Substance:
0/Cyclooxygenase Inhibitors; 0/Lipoxygenase Inhibitors; 0/Vasodilator Agents; 66000-40-6/4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 78919-13-8/Iloprost

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of amiloride A Na+/H+ exchange inhibitor on cardioprotective effect of ischaemic precondition...
Next Document:  Attenuation in rat brain nitric oxide synthase activity in the coarctation model of hypertension.